Response Pharma Completes Enrollment of Phase 2 Study for RDX-002
06 Feb 2025 //
BUSINESSWIRE
Response Pharma Enrolls 1st Patients In Ph 2, Evaluating RDX-002
17 Oct 2024 //
BUSINESSWIRE
Response Pharma AIWG Drug Meets Phase 1b Endpoint
23 Apr 2024 //
BUSINESSWIRE